← Back to Discover
Foresite Capital Management IV, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $290,151,348
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Pharvaris N.V. · COM · N69605108 · shares: $165,243,331
- CYTOKINETICS INC · COM · 23282W605 · shares: $60,884,867
- Eikon Therapeutics, Inc. · COM · 282564103 · shares: $25,365,050
- Relay Therapeutics, Inc. · COM · 75943R102 · shares: $23,387,500
- Xenon Pharmaceuticals Inc. · COM · 98420N105 · shares: $9,657,600
- Crinetics Pharmaceuticals, Inc. · COM · 22663K107 · shares: $5,613,000
Reported holdings
6 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Pharvaris N.V. | COM | N69605108 | — | 4,778,581 shares | $165,243,331 |
| CYTOKINETICS INC | COM | 23282W605 | — | 714,695 shares | $60,884,867 |
| Eikon Therapeutics, Inc. | COM | 282564103 | — | 1,943,682 shares | $25,365,050 |
| Relay Therapeutics, Inc. | COM | 75943R102 | — | 1,250,000 shares | $23,387,500 |
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | — | 160,000 shares | $9,657,600 |
| Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | — | 150,000 shares | $5,613,000 |